Literature DB >> 18784457

CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.

Michael A Kolber1.   

Abstract

OBJECTIVE: Studies have found that CD8 T-cell activation, as measured by CD38 expression, in HIV-1-infected individuals on suppressive therapy for longer than 12 months is not predictive of CD4 T-cell recovery. Owing to the fact that reconstitution of memory and naive T-cell populations occurs differentially over time, this study evaluated whether distinct memory/naive CD4 T-cell subsets correlated with CD38 on CD8 T-cells.
MATERIALS AND METHODS: Whole blood from 13 participants was used to evaluate activation phenotypic markers on CD8 lymphocytes and memory/naive phenotypes on CD4 lymphocytes. These HIV-1-infected individuals had stable CD4 cell counts for more than 1 year while on suppressive combination antiretroviral therapy.
RESULTS: The results demonstrate that CD4 central memory and naive cell populations contribute to the magnitude of CD4 T-cell reconstitution. CD4 central memory has a significant negative correlation with the percentage of CD38-activated CD8 T-cells.
CONCLUSION: This suggests that CD8 activation is important in CD4 recovery from a low CD4 T-cell nadir.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784457     DOI: 10.1097/QAD.0b013e32830f97e2

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Immunological function restoration with lopinavir/ritonavir versus efavirenz containing regimens in HIV-infected patients: a randomized clinical trial.

Authors:  Berta Torres; Norma I Rallón; Montserrat Loncá; Alba Díaz; Llucia Alós; Esteban Martínez; Anna Cruceta; Joan Albert Arnaiz; Lorna Leal; Constanza Lucero; Agathe León; Marcelo Sánchez; Eugenia Negredo; Bonaventura Clotet; José M Gatell; José M Benito; Felipe Garcia
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-10       Impact factor: 2.205

2.  HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.

Authors:  Rachel E Owen; John W Heitman; Dale F Hirschkorn; Marion C Lanteri; Hope H Biswas; Jeffrey N Martin; Melissa R Krone; Steven G Deeks; Philip J Norris
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

3.  Immune activation markers in individuals with HIV-1 disease and their correlation with HIV-1 RNA levels in individuals on antiretroviral therapy.

Authors:  Jyoti Sangwan; Sourav Sen; Rajiv Mohan Gupta; K Shanmuganandan; Rajan S Grewal
Journal:  Med J Armed Forces India       Date:  2019-10-15

4.  Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases.

Authors:  M C Kowarik; V Grummel; S Wemlinger; D Buck; M S Weber; A Berthele; B Hemmer
Journal:  J Neurol       Date:  2013-10-27       Impact factor: 4.849

5.  High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression.

Authors:  Xue Yang; Yan-mei Jiao; Rui Wang; Yun-xia Ji; Hong-wei Zhang; Yong-hong Zhang; De-xi Chen; Tong Zhang; Hao Wu
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

6.  The tetraspanin CD151 marks a unique population of activated human T cells.

Authors:  Mildred D Perez; Lillian Seu; Kelsey E Lowman; David C Moylan; Christopher Tidwell; Shekwonya Samuel; Alexandra Duverger; Frederic H Wagner; Eric Carlin; Vishal Sharma; Brandon Pope; Chander Raman; Nathan Erdmann; Jayme Locke; Hui Hu; Steffanie Sabbaj; Olaf Kutsch
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.